The Evolution of Benzodiazepine Allosteric Modulators: Structural Insights From Historical Milestones to Emerging Innovations in Drug Discovery and Development.

Benzodiazepine drugs (BZDs) have been central to neuropsychopharmacology since the 1960s, acting as positive allosteric modulators of γ-aminobutyric acid type A (GABAA) receptors to enhance inhibitory neurotransmission. Despite their clinical efficacy, long-term use is limited by tolerance, dependence, and cognitive side effects. This review summarizes the structural evolution of BZD modulators, with a focus on subtype-selective interactions with GABAA receptor isoforms. Advances in cryo-electron microscopy and AI-driven modeling have clarified the architecture and pharmacological roles of distinct receptor subunits, enabling the design of ligands that dissociate therapeutic effects from adverse outcomes. We also highlight the development of nonclassical scaffolds-such as imidazopyridines, triazolopyridazines, and cinnolines-which improve metabolic stability and subtype specificity. In addition, emerging formulation technologies and novel indications, including chronic pain, asthma, and neurodegenerative disorders, broaden the therapeutic scope of BZD-related compounds. Collectively, these advances underscore a shift toward rational, structure-based design of next-generation BZD receptor modulators with improved efficacy, safety, and clinical precision.

• Publication year

  2025

• Venue

  Medicinal research reviews (Print)

• Publication date

  2025-11-09

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/med.70026PMID 41208204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dimdazenil for the treatment of insomnia: a systematic review and narrative synthesis

  2024cited by this paper
• Progress in GABAA receptor agonists for insomnia disorder

  2024cited by this paper
• High-resolution real-space reconstruction of cryo-EM structures using a neural field network

  2024cited by this paper
• De novo design of drug-binding proteins with predictable binding energy and specificity

  2024cited by this paper
• Role of GABA pathway in motor and non-motor symptoms in Parkinson's disease: a bidirectional circuit

  2024cited by this paper
• The molecular basis of drug selectivity for α5 subunit-containing GABAA receptors

  2023cited by this paper
• Search for Novel Therapies for Essential Tremor Based on Positive Modulation of α6-Containing GABAA Receptors

  2023cited by this paper
• Deprescribing benzodiazepine receptor agonists for insomnia in older adults.

  2023cited by this paper
• Efficacy and Safety of Anxiolytics in Mohs Micrographic Surgery: A Randomized, Double-Blinded, Placebo-Controlled Trial

  2023cited by this paper
• A phase 1 study of dimdazenil to evaluate the pharmacokinetics, food effect and safety in Chinese healthy subjects

  2023cited by this paper
• GABA tone regulation and its cognitive functions in the brain

  2023cited by this paper
• Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation

  2023cited by this paper
• Design, Synthesis, and Biological Evaluation of Novel Spiro Imidazobenzodiazepines to Identify Improved Inhaled Bronchodilators.

  2023cited by this paper
• Intraindividual Variability in Absolute Bioavailability and Clearance of Midazolam in Healthy Individuals

  2023cited by this paper
• 4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABAA Receptor Subtype

  2023cited by this paper
• 2-(4-Fluorophenyl)-1H-benzo[d]imidazole as a Promising Template for the Development of Metabolically Robust, α1β2γ2GABA-A Receptor-Positive Allosteric Modulators

  2023cited by this paper
• Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health

  2023cited by this paper
• GluD1 binds GABA and controls inhibitory plasticity

  2023cited by this paper
• Initial validation of the expectancies for Benzodiazepine Analgesia Scale.

  2023cited by this paper
• α5GABAA Receptor: A Potential Therapeutic Target for Perioperative Neurocognitive Disorders, a Review of Preclinical Studies.

  2023cited by this paper
• A comparation of dexmedetomidine and midazolam for sedation in patients with mechanical ventilation in ICU: A systematic review and meta-analysis

  2023cited by this paper
• GABAA Receptor Modulators with a Pyrazolo[1,5-a]quinazoline Core: Synthesis, Molecular Modelling Studies and Electrophysiological Assays

  2022cited by this paper
• The fate of interneurons, GABAA receptor sub‐types and perineuronal nets in Alzheimer's disease

  2022cited by this paper
• Walking the Benzodiazepine High Wire.

  2022cited by this paper
• Co-prescribing of Central Nervous System–Active Medications for COPD Patients: Impact on Emergency Room Visits and Hospitalization

  2022cited by this paper
• Structural and dynamic mechanisms of GABAA receptor modulators with opposing activities

  2022cited by this paper
• The GABAA receptor modulator zolpidem augments hippocampal-prefrontal coupling during non-REM sleep

  2022cited by this paper
• Maternal and neonatal outcomes with the addition of intrathecal midazolam as an adjuvant to spinal anesthesia in cesarean delivery: A systematic review and meta-analysis of randomized controlled trials.

  2022cited by this paper
• Differential assembly diversifies GABAA receptor structures and signalling

  2022cited by this paper
• Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO)

  2022cited by this paper
• Qualitative analysis of 7- and 8-hydroxyzolpidem and discovery of novel zolpidem metabolites in postmortem urine using liquid chromatography–tandem mass spectrometry

  2022cited by this paper
• Airway smooth muscle pathophysiology in asthma.

  2021cited by this paper
• Sedation outcomes for remimazolam, a new benzodiazepine.

  2021cited by this paper
• Remimazolam alleviates neuropathic pain via regulating bradykinin receptor B1 and autophagy.

  2021cited by this paper
• Benzodiazepines increase the likelihood of both infectious and thrombotic complications

  2021cited by this paper
• VALTOCO® (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity

  2021cited by this paper
• Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters

  2021cited by this paper
• Preparation, optimization, and evaluation of midazolam nanosuspension: enhanced bioavailability for buccal administration

  2021cited by this paper
• Design, synthesis, and preliminary pharmacological evaluation of novel thiazolidinone derivatives as potential benzodiazepine agonists

  2021cited by this paper
• Preparation, Characterization, and In vivo Biodistribution Study of Intranasal 131I-Clonazepam-Loaded Phospholipid Magnesome as a Promising Brain Delivery System: Biodistribution and pharmacokinetic behavior of intranasal 131I-Clonazepam loaded phospholipid magnesome as a potential brain targeting s

  2021cited by this paper
• GABAA receptors: structure, function, pharmacology, and related disorders

  2021cited by this paper
• GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia

  2021cited by this paper
• Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent

  2021cited by this paper
• Mono- and poly-therapy with benzodiazepines or Z-drugs: Results from a tertiary-care Addiction Unit study

  2021cited by this paper
• Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial

  2020cited by this paper
• The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study

  2020cited by this paper
• Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments

  2020cited by this paper
• Etizolam: A rapid review on pharmacology, non-medical use and harms.

  2020cited by this paper
• Mesophasic organization of GABAA receptors in hippocampal inhibitory synapses

  2020cited by this paper
• Allosteric GABAA Receptor Modulators—A Review on the Most Recent Heterocyclic Chemotypes and Their Synthetic Accessibility

  2020cited by this paper
• In-vitro and in-vivo evaluation of chitosan-based thermosensitive gel containing lorazepam NLCs for the treatment of status epilepticus.

  2020cited by this paper
• Identification of the Functional Binding Site for the Convulsant Tetramethylenedisulfotetramine in the Pore of the α2β3γ2 GABAA Receptor

  2020cited by this paper
• Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study.

  2020cited by this paper
• Cryo-EM: The Resolution Revolution and Drug Discovery

  2020cited by this paper
• Enhancement of Muscimol Binding and Gating by Allosteric Modulators of the GABAA Receptor: Relating Occupancy to State Functions.

  2020cited by this paper
• The α2/α3GABAA receptor modulator TPA023B alleviates not only the sensory but also the tonic affective component of chronic pain in mice

  2020cited by this paper
• Enhancement of Muscimol Binding and Gating by Allosteric Modulators of the GABAA Receptor: Relating Occupancy to State Functions

  2020cited by this paper
• PLGA nanoparticles for nose to brain delivery of Clonazepam: formulation, optimization by 32 Factorial design, in vitro and in vivo evaluation.

  2020cited by this paper
• Design, synthesis and neuropharmacological evaluation of new 2,4-disubstituted-1,5-benzodiazepines as CNS active agents.

  2020cited by this paper
• GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment

  2020cited by this paper
• Do Benzodiazepines Cause Alzheimer's Disease?

  2020cited by this paper
• Nanostructured Lipid Carriers to Mediate Brain Delivery of Temazepam: Design and In Vivo Study

  2020cited by this paper
• Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia

  2020cited by this paper
• Eszopiclone for the treatment of primary insomnia: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.

  2019cited by this paper
• A novel GABAA receptor ligand MIDD0301 with limited blood-brain barrier penetration relaxes airway smooth muscle ex vivo and in vivo.

  2019cited by this paper
• Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer

  2019cited by this paper
• The effect of short-term use of benzodiazepines on cognitive function of major depressive disorder patients being treated with antidepressants.

  2019cited by this paper
• Inhaled alprazolam rapidly suppresses epileptic activity in photosensitive participants

  2019cited by this paper
• Burst and Tonic Spinal Cord Stimulation Both Activate Spinal GABAergic Mechanisms to Attenuate Pain in a Rat Model of Chronic Neuropathic Pain

  2019cited by this paper
• The Positive Allosteric Modulator of α2/3-Containing GABAA Receptors, KRM-II-81, Is Active in Pharmaco-Resistant Models of Epilepsy and Reduces Hyperexcitability after Traumatic Brain Injury

  2019cited by this paper
• Pharmacotherapy for Pediatric Convulsive Status Epilepticus

  2019cited by this paper
• Clobazam monotherapy for focal or generalized seizures.

  2018cited by this paper
• Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer’s Disease

  2018cited by this paper
• Potentiating α2 subunit containing perisomatic GABAA receptors protects against seizures in a mouse model of Dravet Syndrome

  2018cited by this paper
• A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.

  2018cited by this paper
• Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABAAR) α6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability.

  2018cited by this paper
• The Benzodiazepine Binding Sites of GABAA Receptors.

  2018cited by this paper
• Cryo-EM structure of the human α5β3 GABAA receptor

  2018cited by this paper
• Structure of a human synaptic GABA-A receptor

  2018cited by this paper
• Bioisosteres of ethyl 8‐ethynyl‐6‐(pyridin‐2‐yl)‐4H‐benzo[f]imidazo [1,5‐a][1,4]diazepine‐3‐carboxylate (HZ‐166) as novel alpha 2,3 selective potentiators of GABAA receptors: Improved bioavailability enhances anticonvulsant efficacy

  2018cited by this paper
• Pharmacokinetics of clobazam oral soluble film

  2018cited by this paper
• Physiological and pharmacological properties of inhibitory postsynaptic currents mediated by α5β1γ2, α5β2γ2 and α5β3γ2 GABAA receptors.

  2017cited by this paper
• Novel 4-thiazolidinone derivatives as agonists of benzodiazepine receptors: Design, synthesis and pharmacological evaluation

  2017cited by this paper
• GABAA Receptors and the Diversity in their Structure and Pharmacology.

  2017cited by this paper
• GABA‐ρ receptors: distinctive functions and molecular pharmacology

  2017cited by this paper
• Synthesis and pharmacological evaluation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as potential GABAA-R ligands.

  2017cited by this paper
• Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia

  2017cited by this paper
• Use of Fall-Risk Inducing Drugs in Patients Using Anti-Parkinson Drugs (APD): A Swedish Register-Based Study

  2016cited by this paper
• Development of GABAA Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments.

  2016cited by this paper
• Single dose efficacy evaluation of two partial benzodiazepine receptor agonists in photosensitive epilepsy patients: A placebo-controlled pilot study.

  2016cited by this paper
• Toward Understanding Functional Properties and Subunit Arrangement of α4β2δ γ-Aminobutyric Acid, Type A (GABAA) Receptors*

  2016cited by this paper
• Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state

  2016cited by this paper
• Nose to Brain Delivery of Midazolam Loaded PLGA Nanoparticles: In Vitro and In Vivo Investigations.

  2016cited by this paper
• Review of Safety and Efficacy of Sleep Medicines in Older Adults.

  2016cited by this paper
• Pubertal Expression of α4βδ GABAA Receptors Reduces Seizure-Like Discharges in CA1 Hippocampus

  2016cited by this paper
• Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease

  2016cited by this paper
• GABAA receptor occupancy by subtype selective GABAAα2,3 modulators: PET studies in humans

  2016cited by this paper
• Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action

  2015cited by this paper
• Benzodiazepine ligands rapidly influence GABAA receptor diffusion and clustering at hippocampal inhibitory synapses.

  2015cited by this paper
• Safety and efficacy of diazepam autoinjector for the management of epilepsy

  2015cited by this paper

• No citing papers are available for this paper.